India's health ministry has written to the All India Organisation of Chemists and Druggists (AIOCD), saying its members should ensure availability of critical drugs to treat COVID-19 patients and other essential medicines during the pandemic, reported The Hindu.
The ministry has forwarded a list of 55 drugs for intensive care unit (ICU) management of novel coronavirus patients and a list of another 96 drugs for general availability and treatment of various co-morbid conditions.
The letter noted that in accordance with clinical management guidelines of COVID-19 in the country, hydroxychloroquine has been recommended as prophylaxis for certain categories like healthcare workers and household contacts of positive cases.
A combination of hydorxychloroquine and azithromycin has been prescribed for severe patients requiring ICU management, while some other drugs are also presently under various stages of testing, but have so far not been recommended for use in India, the letter stated.
To read more NewsPoints articles, click here.